Document is current
Any future updates will be listed below
-
Authors
Aguirre-Ghiso, Julio A. https://orcid.org/0000-0002-6694-6507
Bravo-Cordero, Jose Javier https://orcid.org/0000-0001-9481-1231
Guo, Wenjun https://orcid.org/0000-0002-6960-7957
Lauvau, Gregoire
Sosa, Maria Soledad
- License Information
-
More Information
Article History
Accepted: 17 March 2026
First Online: 24 April 2026
Competing interests
: J.A.A.-G. is a co-founder, advisory board member and equity holder in HiberCell, a Mount Sinai spin-off developing cancer recurrence prevention therapies. J.A.A.-G. consults Astrin Biosciences and serves as chairman of the scientific advisory board of the Samuel Waxman Institute for Aging and Cancer at The Mark Foundation and he has ownership interest in patent number WO2019191115A1/ EP-3775171-B1. J.J.B.C is a consultant for HTL Biotechnology. G.L., W.G. and M.S.S. have nothing to declare.
